Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

A sensitive assay for urinary cocaine metabolite benzoylecgonine shows more positive results and longer half-lives than those using traditional cut-offs.

Nickley J, Pesce AJ, Krock K.

Drug Test Anal. 2017 Aug;9(8):1214-1216. doi: 10.1002/dta.2153. Epub 2017 Mar 3.

2.

Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting.

Crews BO, Pesce AJ, West R, Nguyen H, Fitzgerald RL.

J Anal Toxicol. 2012 Nov-Dec;36(9):601-7. doi: 10.1093/jat/bks071. Epub 2012 Sep 19.

PMID:
22995480
3.

Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data.

Barakat NH, Atayee RS, Best BM, Pesce AJ.

J Anal Toxicol. 2012 May;36(4):257-64. doi: 10.1093/jat/bks019.

PMID:
22511700
4.

Observations on the metabolism of morphine to hydromorphone in pain patients.

Hughes MM, Atayee RS, Best BM, Pesce AJ.

J Anal Toxicol. 2012 May;36(4):250-6. doi: 10.1093/jat/bks021.

PMID:
22511699
5.

Evaluating the relationship of methadone concentrations and EDDP formation in chronic pain patients.

Leimanis E, Best BM, Atayee RS, Pesce AJ.

J Anal Toxicol. 2012 May;36(4):239-49. doi: 10.1093/jat/bks020.

PMID:
22511698
6.

Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.

Yee DA, Best BM, Atayee RS, Pesce AJ.

J Anal Toxicol. 2012 May;36(4):232-8. doi: 10.1093/jat/bks022.

PMID:
22511697
7.
8.

Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety.

Mikel C, Pesce AJ, Rosenthal M, West C.

Clin Chim Acta. 2012 Aug 16;413(15-16):1199-202. doi: 10.1016/j.cca.2012.03.017. Epub 2012 Mar 29.

PMID:
22484396
9.

Dilute and shoot: analysis of drugs of abuse using selected reaction monitoring for quantification and full scan product ion spectra for identification.

Fitzgerald RL, Griffin TL, Yun YM, Godfrey RA, West R, Pesce AJ, Herold DA.

J Anal Toxicol. 2012 Mar;36(2):106-11. doi: 10.1093/jat/bkr024.

PMID:
22337779
10.

Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash.

Reisfield GM, Goldberger BA, Pesce AJ, Crews BO, Wilson GR, Teitelbaum SA, Bertholf RL.

J Anal Toxicol. 2011 Jun;35(5):264-8.

PMID:
21619720
11.

Determination of illicit drug cutoff values in a pain patient population.

West R, Pesce AJ, Crews B, Mikel C, Rosenthal M, Almazan P, Latyshev S, West C.

Clin Chim Acta. 2011 Aug 17;412(17-18):1589-93. doi: 10.1016/j.cca.2011.05.004. Epub 2011 May 12.

PMID:
21600890
12.

Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to an ethanol-based hand sanitizer.

Reisfield GM, Goldberger BA, Crews BO, Pesce AJ, Wilson GR, Teitelbaum SA, Bertholf RL.

J Anal Toxicol. 2011 Mar;35(2):85-91.

PMID:
21396227
13.

Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration.

Norman AB, Norman MK, Tabet MR, Tsibulsky VL, Pesce AJ.

Synapse. 2011 May;65(5):404-11. doi: 10.1002/syn.20858. Epub 2010 Oct 8.

14.

Anomalous observations of hydrocodone in patients on oxycodone.

West R, West C, Crews B, Almazan P, Latyshev S, Rosenthal M, Pesce AJ, Mikel C.

Clin Chim Acta. 2011 Jan 14;412(1-2):29-32. doi: 10.1016/j.cca.2010.08.029. Epub 2010 Aug 27.

PMID:
20801109
15.

Used equipment choices.

Pesce AJ, Tirakis E.

MLO Med Lab Obs. 2010 Apr;42(4):68-9. No abstract available.

PMID:
20446477
16.

Variability of transdermal fentanyl metabolism and excretion in pain patients.

Cole JM, Best BM, Pesce AJ.

J Opioid Manag. 2010 Jan-Feb;6(1):29-39.

PMID:
20297612
17.

A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice.

Norman AB, Tabet MR, Norman MK, Buesing WR, Pesce AJ, Ball WJ.

J Pharmacol Exp Ther. 2007 Jan;320(1):145-53. Epub 2006 Oct 5.

PMID:
17023573
18.

Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults.

Miles MV, Horn PS, Tang PH, Morrison JA, Miles L, DeGrauw T, Pesce AJ.

Clin Chim Acta. 2004 Sep;347(1-2):139-44.

PMID:
15313151
19.

Coenzyme Q10 changes are associated with metabolic syndrome.

Miles MV, Morrison JA, Horn PS, Tang PH, Pesce AJ.

Clin Chim Acta. 2004 Jun;344(1-2):173-9.

PMID:
15149886
20.

Reference intervals: an update.

Horn PS, Pesce AJ.

Clin Chim Acta. 2003 Aug;334(1-2):5-23. Review.

PMID:
12867273
21.

Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults.

Miles MV, Horn PS, Morrison JA, Tang PH, DeGrauw T, Pesce AJ.

Clin Chim Acta. 2003 Jun;332(1-2):123-32.

PMID:
12763289
22.

Effect of ethnicity on reference intervals.

Horn PS, Pesce AJ.

Clin Chem. 2002 Oct;48(10):1802-4. No abstract available.

23.

Urine drug screening in the medical setting.

Hammett-Stabler CA, Pesce AJ, Cannon DJ.

Clin Chim Acta. 2002 Jan;315(1-2):125-35. Review.

PMID:
11728415
24.

Effect of outliers and nonhealthy individuals on reference interval estimation.

Horn PS, Feng L, Li Y, Pesce AJ.

Clin Chem. 2001 Dec;47(12):2137-45.

25.

Reference interval computation using robust vs parametric and nonparametric analyses.

Horn PS, Pesce AJ, Copeland BE.

Clin Chem. 1999 Dec;45(12):2284-5. No abstract available.

26.
27.

A robust approach to reference interval estimation and evaluation.

Horn PS, Pesce AJ, Copeland BE.

Clin Chem. 1998 Mar;44(3):622-31.

28.

Clinical chemistry and post-liver-transplant monitoring.

Hickman PE, Potter JM, Pesce AJ.

Clin Chem. 1997 Aug;43(8 Pt 2):1546-54. Review.

29.
30.

Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.

Stretcher BN, Pesce AJ, Frame PT, Greenberg KA, Stein DS.

AIDS. 1994 Jun;8(6):763-9.

PMID:
8086134
31.

Pathology and laboratory medicine.

Fenoglio-Preiser CM, Pesce AJ.

JAMA. 1993 Jul 14;270(2):245-6. No abstract available.

PMID:
8315749
32.

Electrochemical homogeneous enzyme immunoassay of theophylline in hemolyzed, icteric, and lipemic samples.

Yao H, Jenkins SH, Pesce AJ, Halsall HB, Heineman WR.

Clin Chem. 1993 Jul;39(7):1432-4.

33.

Clinical correlations of cyclosporine-specific and -nonspecific assays in stable renal transplants, acute rejection, and cyclosporine nephrotoxicity.

Schroeder TJ, Sridhar N, Pesce AJ, Alexander JW, First MR.

Ther Drug Monit. 1993 Jun;15(3):190-4.

PMID:
8332997
34.

Monoethylglycinexylide formation in assessing pediatric donor liver function.

Rossi SJ, Schroeder TJ, Vine WH, A-Kader HH, Gremse DA, Ryckman FC, Pedersen SH, Pesce AJ, Balistreri WF.

Ther Drug Monit. 1992 Dec;14(6):452-6.

PMID:
1485364
35.

Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus.

Stretcher BN, Pesce AJ, Hurtubise PE, Frame PT.

Ther Drug Monit. 1992 Aug;14(4):281-5.

PMID:
1519301
36.

Artifacts and limitations of enzyme immunoassay.

Pesce AJ, Michael JG.

J Immunol Methods. 1992 Jun 24;150(1-2):111-9. Review. No abstract available.

PMID:
1613248
37.

The role of the laboratory in the use of biotech drugs: a call to arms.

Pesce AJ, Warner AM.

Ann Clin Lab Sci. 1992 May-Jun;22(3):197-200. No abstract available.

PMID:
1503386
38.
39.

Electrochemical determination of azidothymidine in human whole blood.

Barone GC 3rd, Pesce AJ, Halsall HB, Heineman WR.

Anal Biochem. 1991 Oct;198(1):6-9.

PMID:
1665018
40.

Intracellular monitoring of nucleoside analogues: a new frontier.

Stretcher BN, Pesce AJ.

Ann Clin Lab Sci. 1991 Sep-Oct;21(5):340-2. No abstract available.

PMID:
1952783
42.

Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations.

Stretcher BN, Pesce AJ, Murray JA, Hurtubise PE, Vine WH, Frame PT.

Ther Drug Monit. 1991 Jul;13(4):325-31.

PMID:
1780965
43.

Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.

First MR, Schroeder TJ, Alexander JW, Stephens GW, Weiskittel P, Myre SA, Pesce AJ.

Transplantation. 1991 Feb;51(2):365-70.

PMID:
1994529
44.

Selection criteria for liver transplant donors.

Schroeder TJ, Pesce AJ, Ryckman FC, Tressler TP, Brunson ME, Pedersen SH, Tchervenkov JI, Penn I, Alexander JW, Balistreri WF.

J Clin Lab Anal. 1991;5(4):275-7.

PMID:
1890541
45.

Critical ketoconazole dosage range for ciclosporin clearance inhibition in the dog.

Myre SA, Schoeder TJ, Grund VR, Wandstrat TL, Nicely PG, Pesce AJ, First MR.

Pharmacology. 1991;43(5):233-41.

PMID:
1784623
46.

In vitro measurement of phosphorylated zidovudine in peripheral blood leucocytes.

Stretcher BN, Pesce AJ, Wermeling JR, Hurtubise PE.

Ther Drug Monit. 1990 Sep;12(5):481-9.

PMID:
2293412
47.

Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.

Sridhar N, Schroeder TJ, Pesce AJ, First MR.

Transplant Proc. 1990 Jun;22(3):1257-9. No abstract available.

PMID:
2190387
48.

An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.

Pesce AJ, Schroeder TJ, First MR.

Transplant Proc. 1990 Jun;22(3):1171-4. No abstract available.

PMID:
2190376
49.

Cationization of protein antigens. V. Effect of the degree of cationization on patterns of immune responsiveness.

Muckerheide A, Pesce AJ, Michael JG.

Cell Immunol. 1990 Apr 15;127(1):67-77.

PMID:
1690611
50.

Modulation of the immune response to allergens: phospholipase A degradation products suppress IgG and IgE response in mice.

Pesce AJ, Freisheim JM, Litwin A, Michael JG.

Int Arch Allergy Appl Immunol. 1990;92(1):88-93.

PMID:
2246080

Supplemental Content

Loading ...
Support Center